Univariate and multivariate analysis of factors associated with the survival and progression of stage III HCC patients who underwent TACE (n = 30).

Abbreviations: OS, overall survival; TTP: time to progression; HR: hazard ratio; CI: confidence interval; HBsAg, hepatitis B surface antigen; AFP, alpha-fetoprotein; LDH, lactate dehydrogenase; INR, international normalized ratio; SD, stable disease; PD, progressive disease; CR, complete response; PR, partial response; D30, 30 days after TACE; Th17D0, the percentage of Th17 cells in CD4+ T cells before TACE; Th17D30, the percentage of Th17 cells in CD4+ T cells 30 days after TACE; NA, not applicable.